Should we really compare absolute risk reduction in different trials on osteoporosis: comment on the article by Ringe JD and Doherty JG.
Zhanna E
ZE
Belaya
D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D005260:Female; D050723:Fractures, Bone / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000150:complications* / Q000188:drug therapy*; D017063:Outcome Assessment, Health Care / Q000379:methods*; D040242:Risk Reduction Behavior
D050071:Bone Density Conservation Agents